Project Grant R01DA064512
- This federal Project Grant award for $188,995.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research at the University of Pittsburgh focused on understanding, preventing, and treating substance use disorders. The project aims to develop novel interventions, explore neuroscientific mechanisms of addiction, and improve treatment strategies. The...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This federal Project Grant award of $158,246.00 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will support research under the Drug Use and Addiction Research Programs (CFDA 93.279). The award will fund a comprehensive, longitudinal study investigating the co-occurrence of trauma, substance use, and additional stressors among Americans from childhood through adulthood. The research aims to elucidate the etiological trajectories of co-occurring...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $677,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant, awarded on June 15, 2025, supports the development and testing of the "Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention" for implementation in syringe service programs. The project aims to engage women with experiences of...
- This federal Project Grant award of $769,708 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is for the "Drug Use and Addiction Research Programs" (CFDA 93.279). The award supports research to adapt and pilot test the Brief Negotiation Interview (BNI) for use among assault-injured emerging adults (ages 18-25) with alcohol and/or cannabis misuse who seek care in the emergency department setting. Key objectives include eliciting shared...
- This federal Project Grant award of $661,850 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports a hybrid Type I trial to assess the effectiveness and implementation of a peer-led court navigator program that facilitates linkage to substance use disorder treatment. The award will fund a randomized controlled trial to compare the effectiveness of the court...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,445,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to New York University School of Medicine. The grant, titled "Characterizing Complex OUD Care Trajectories and Outcomes Following Acute Service Utilization: A Population-Based Data Linkage Study," aims to apply novel research approaches to better understand real-world opioid use disorder (OUD)...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a study to characterize treatment utilization and identify predictors of treatment engagement during the critical community re-entry period for adults with opioid use disorder (OUD) who have completed residential OUD treatment. The $147,486 award, with a performance period from December 20, 2024 to August 31, 2026, will leverage innovative...
- This $643,285 Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a multisite study to assess the reach, effectiveness, and implementation of three different models of Oregon's new "deflection" programs. Deflection programs are partnerships between public safety and public health agencies that aim to divert people with substance use disorder away from the criminal justice system and...
- This $189,500.00 Project Grant award was provided by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to determine the extent to which cardiovascular disease (CVD) affects people with opioid use disorder (OUD) and identify ways to prevent CVD in this population. To achieve this, the project will: 1) Examine the relationship between CVD and OUD using Transformed...
This federal Project Grant award of $770,461.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant, titled "Police Pathways to Addiction Treatment, Health, and Safety: The Police PATHS Study", aims to investigate implementation gaps in police-assisted diversion (PAD) programs that link people who use drugs (PWUD) to treatment and services, especially medications for opioid use disorder. The project will employ qualitative methods, including semi-structured interviews, to construct implementation research logic models for PAD programs in Philadelphia and Baltimore. This research seeks to evaluate the feasibility, acceptability, appropriateness, fidelity, and sustainability of PAD interventions in order to maximize their impact in reducing overdose and improving health outcomes. The award period runs from September 15, 2025 to May 31, 2030 and is being conducted by the Rhode Island Hospital, a division of Lifespan Corporation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $770.5k | 9/10/25 |